PALISADE BIO, INC.

PALIReported to SECin USCIK 0001357459Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 16. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 16
Form 4 lines at PALISADE BIO, INC., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Finley John DavidCEO, CFOGiftnothing paid88,400 sharesAug 21, 2026Finley John DavidCEO, CFOnothing paidGift · Aug 21Gift88,400Aug 21, 2026
Finley John DavidCEO, CFOGiftnothing paid88,400 sharesAug 21, 2026Finley John DavidCEO, CFOnothing paidGift · Aug 21Gift88,400Aug 21, 2026
Baltera Robert Jr.—Open-market buy$48,90025,000 sharesJul 10, 2026Baltera Robert Jr.$48,900Buy · Jul 10Open-market buy25,000Jul 10, 2026
Baltera Robert Jr.—Open-market buy$39,79820,000 sharesJul 10, 2026Baltera Robert Jr.$39,798Buy · Jul 10Open-market buy20,000Jul 10, 2026
Baltera Robert Jr.—Open-market buy$61,04430,000 sharesJul 8, 2026Baltera Robert Jr.$61,044Buy · Jul 8Open-market buy30,000Jul 8, 2026